Nathan Holtz, PhD, received his PhD in cognitive and biological psychology at the University of Minnesota, studying how individual differences contribute to vulnerability for substance use disorders. He joined the Napier laboratory in 2013, where he is currently investigating the relationship between Parkinson’s disease and impulse control disorders. Together, Dr. Holtz has seven years of experience in behavioral pharmacology working with models of human psychiatric disorders.